EurekAlert! -
30 May 2018 06:00
(ECOG-ACRIN Cancer Research Group) NCI-MATCH (Molecular Analysis for Therapy Choice), the largest precision medicine trial of its kind, achieves a milestone with the release of results from three treatment arms of the trial at the American Society of Clinical Oncology (ASCO) 2018 annual meeting. Spokespersons are available for interviews.
Share this Article